Benicar

Daiichi-Sankyo Announces Benicar Settlement in Strongly Worded Press Release

daiichi-sankyo announces benicar settlement“The impact to the financial position of the company is not considered material because, upon presentation of proper claim documentation, the settlement fund is expected to be comprised primarily of proceeds from several of Daiichi Sankyo Group’s insurance companies supplemented with company funds.

Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”

We don’t believe we did anything wrong and it doesn’t matter much anyway ...

continue reading...

Federal Benicar Lawsuits Selected for Potential Bellwether Trial in MDL

benicar lawsuits selected for federal mdlThe U.S. District Court for the District of New Jersey has announced a pool of 30 federal Benicar lawsuits that will be considered for bellwether trial. The announcement follows a November order detailing how these cases would be randomly selected by the court.

Over 1,100 Benicar lawsuits are pending in a New Jersey multidistrict litigation, according to recent court estimates. Plaintiffs who have filed Benicar lawsuits claim that Japanese ...

continue reading...

Texas Woman Alleges Benicar Caused Her Diverticulitis

benicar possibly linked to diverticulitisA Texas resident has filed a Benicar lawsuit in which she claims Daiichi Sankyo’s blood pressure medication caused her to develop diverticulitis.

Diverticulitis, a digestive disease wherein small pouches in the intestines or colon become inflamed, can lead to severe pain, fever, nausea, and diarrhea. It is just one of several serious gastrointestinal problems that have been associated with Benicar. In 2013, the U.S. Food and Drug Administration (FDA) released ...

continue reading...

Benicar Lawsuit Depositions Slated to Begin January

benicar lawsuit depositions to begin in 2016Depositions are expected to begin early next year for over 1,000 federal Benicar lawsuits filed by patients who claim the blood pressure drug caused severe gastrointestinal problems. In a recent court order, U.S. Magistrate Judge Joel Schneider scheduled depositions of defendants’ employees to commence on January 18, with two depositions each week until February 26.

Benicar, Daiichi Sankyo’s brand-name olmesartan, was approved in 2002 by the U.S. Food and Drug ...

continue reading...

New Study: Benicar Side Effects Resemble Celiac Disease Symptoms

benicar side effects resemble celiac symptomsA new study in the journal Alimentary Pharmacology and Therapeutics has found that intestinal side effects caused by using Benicar (olmesartan) are similar to the symptoms of celiac disease.

Benicar is Japan-based company Daiichi Sankyo’s bestselling hypertension drug. The U.S. Food and Drug Administration (FDA) approved Benicar in 2002, and since then the drug has been prescribed to over 11 million U.S. patients. But in 2013, the ...

continue reading...

First Federal Benicar Lawsuit Trial Set for Late 2016

federal benicar lawsuits set to start in late 2016Following a September 30 status conference, the first Benicar multidistrict litigation lawsuit has been scheduled for trial in late 2016, reports the New Jersey Law Journal.

The litigation, overseen by District Judge Michael Schneider in the U.S. District Court for the District of New Jersey, already includes over 1,100 Benicar lawsuits. These have been filed by patients who claim Daiichi Sankyo’s hypertension drug Benicar caused ...

continue reading...
Page 1 of 7 12345...»